Unternehmen Veloxis Pharmaceuticals A/S CBOE EUROPE EQUITIES
Aktien
A0LEJ1
DK0060048148
0IVI
Pharmazeutika
Schlusskurs
Andere Börsenplätze
|
||
- DKK | - |
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Stacy Wheeler
COO | Chief Operating Officer | - | 01.03.16 |
Chief Tech/Sci/R&D Officer | - | 13.09.17 | |
Lionel Rostaing
PRN | Corporate Officer/Principal | - | - |
Josep Grinyo
PRN | Corporate Officer/Principal | - | - |
Noel Barnard
LAW | General Counsel | - | 01.03.16 |
Mark Hensley
PRN | Corporate Officer/Principal | - | 01.04.16 |
Rita L. Mannella
HRO | Human Resources Officer | - | 01.01.17 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 1 739 741 590 | 173 932 405 ( 9,998 %) | 0 | 9,998 % |
Unternehmenskontakt
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Veloxis Pharmaceuticals, Inc.
Veloxis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Asahi Kasei Corp., Veloxis Pharmaceuticals, Inc. manufactures pharmaceuticals for kidney transplant patients. The company is based in Edison, NJ. |
Pharmaceuticals: Major
|
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+15.54% | 78.51 Mrd. | |
+12.05% | 9 Mrd. | |
+58.17% | 4.96 Mrd. | |
-14.94% | 4.84 Mrd. | |
-.--% | 3.72 Mrd. | |
-26.63% | 2.19 Mrd. | |
+16.75% | 2.12 Mrd. | |
-37.97% | 1.94 Mrd. | |
-6.29% | 1.49 Mrd. |
- Börse
- Aktien
- A0LEJ1 Aktie
- A0LEJ1 Aktie
- Unternehmen Veloxis Pharmaceuticals A/S